Email
Password
Remember meForgot password?
    Log in with Twitter

adverse event reporting News

FDA issues warning on new class of Type-2 diabetes medications

The U.S. Food and Drug Administration on Friday warned that a new class of drugs used to treat type-2 diabetes may cause severe episodes of ketoacidosis, a serious condition where the body produces too much blood acids, called ketones.
 

Search Digital Journal Archives


Set up a news alert for

adverse event reporting


adverse event reporting Image


Latest News
Top News